As the global economy mends, the 2021 growth of Docetaxel Injection will have significant change from previous year. According to our (LP Information) latest study, the global Docetaxel Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Docetaxel Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Docetaxel Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Docetaxel Injection market, reaching US$ million by the year 2028. As for the Europe Docetaxel Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Docetaxel Injection players cover Sanofi, Accord Healthcare, Alkem Labs, and AuroMedics Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Docetaxel Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
10mg/ml
20mg/ml
40mg/ml
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adenocarcinoma
Non-small Cell Tumor
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Stomach Cancer
Head and Neck Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
Accord Healthcare
Alkem Labs
AuroMedics Pharma
Dr. Reddy’s Laboratories
Fresenius Kabi
Getwell Oncology
GLS Pharma
Hikma
Hospira
Pfizer
Seacross Pharmaceuticals
Teikoku Pharma USA
Teva Pharmaceuticals USA
Xiromed
Aosaikang Pharmaceutical
Beijing Union Pharmaceutical Factory
Cisen Pharmaceutical
Acebright Pharmaceuticals
Hisun Pharmaceutical
Hanhui Pharmaceutical
Hengrui Pharmaceuticals
Meida Kangjiale
Qilu Pharmaceutical
Taiji Pharmaceutical
Wansheng Pharmaceutical
Main Luck Pharmaceuticals
Yangtze River Pharmaceutical
Chia Tal-tianqing Pharmaceutical